Treatment of nongenital cutaneous warts
- PMID: 21842775
Treatment of nongenital cutaneous warts
Abstract
Numerous treatments for nongenital cutaneous warts are available, although no single therapy has been established as completely curative. Watchful waiting is an option for new warts because many resolve spontaneously. However, patients often request treatment because of social stigma or discomfort. Ideally, treatment should be simple and inexpensive with low risk of adverse effects. Salicylic acid has the best evidence to support its effectiveness, but it is slow to work and requires frequent application for up to 12 weeks. Cryotherapy with liquid nitrogen is a favorable option for many patients, with cure rates of 50 to 70 percent after three or four treatments. For recalcitrant warts, Candida or mumps skin antigen can be injected into the wart every three to four weeks for up to three treatments. More expensive treatments for recalcitrant warts are offered in many dermatology offices. Photodynamic therapy with aminolevulinic acid has the best evidence of effectiveness compared with pulsed dye laser, intralesional bleomycin, and surgical removal using curettage or cautery.
Comment in
-
Electrodesiccation and curettage for removal of nongenital warts.Am Fam Physician. 2012 Apr 15;85(8):e2; author reply e2. Am Fam Physician. 2012. PMID: 22534396 No abstract available.
Similar articles
-
Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.Arch Dermatol. 2001 Apr;137(4):451-5. Arch Dermatol. 2001. PMID: 11295925
-
Recalcitrant nongenital warts.Aust Fam Physician. 2011 Jan-Feb;40(1-2):40-2. Aust Fam Physician. 2011. PMID: 21301692 Review.
-
Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.Arch Dermatol. 2005 May;141(5):589-94. doi: 10.1001/archderm.141.5.589. Arch Dermatol. 2005. PMID: 15897380 Clinical Trial.
-
Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.J Drugs Dermatol. 2004 May-Jun;3(3):263-5. J Drugs Dermatol. 2004. PMID: 15176159 Clinical Trial.
-
Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials.Br J Dermatol. 2011 Aug;165(2):233-46. doi: 10.1111/j.1365-2133.2011.10218.x. Epub 2011 May 26. Br J Dermatol. 2011. PMID: 21219294 Review.
Cited by
-
Transcriptome analysis of HPV-induced warts and healthy skin in humans.BMC Med Genomics. 2020 Mar 9;13(1):35. doi: 10.1186/s12920-020-0700-7. BMC Med Genomics. 2020. PMID: 32151264 Free PMC article.
-
Global gene methylation profiling of common warts caused by human papillomaviruses infection.Saudi J Biol Sci. 2021 Jan;28(1):612-622. doi: 10.1016/j.sjbs.2020.10.050. Epub 2020 Nov 2. Saudi J Biol Sci. 2021. PMID: 33424347 Free PMC article.
-
Off-label photodynamic therapy for recalcitrant facial flat warts using topical 5-aminolevulinic acid.Lasers Med Sci. 2016 Jul;31(5):929-36. doi: 10.1007/s10103-016-1925-8. Epub 2016 Apr 8. Lasers Med Sci. 2016. PMID: 27059226
-
Digital necrosis following combined liquid nitrogen and candida antigen therapy for digital warts.JAAD Case Rep. 2023 Jul 7;39:142-144. doi: 10.1016/j.jdcr.2023.06.037. eCollection 2023 Sep. JAAD Case Rep. 2023. PMID: 37693928 Free PMC article. No abstract available.
-
Towards Formulation of Highly Acidic Active Ingredients: Development of Clinically Effective Concentrated Trichloroacetic Acid Gel for Wart Management.AAPS PharmSciTech. 2023 Jul 27;24(6):160. doi: 10.1208/s12249-023-02615-7. AAPS PharmSciTech. 2023. PMID: 37498470
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical